Marc LePage served as President and CEO of Genome Canada from 2016 to 2021. He led an ambitious national research program which invested approximately $200M/year to support close to 1800 scientists working on applications of genomics in human health, agriculture, forestry, natural resources, fisheries, and the environment/climate change etc. He developed a number of important partnerships including a national effort to implement a country-wide clinical genomics initiative for rare disease patients. He was President and CEO of Genome Quebec from 2012 to 2016 where he worked closely with the provincial government to align research with public policy priorities. He spent many years abroad as a member of Canada’s foreign service. In 2005 he was appointed Consul-General San Francisco/Silicon Valley and launched new commercialization programs including the “Technology Accelerator Program” for emerging Canadian firms as well as the “C-100” venture capital network to facilitate access to Silicon Valley investment funds. Both of these programs were highly successful and have been replicated in other locations in the USA.